Q32 Bio Files 8-K Report
Ticker: QTTB · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, 8-K
TL;DR
Q32 Bio filed an 8-K on 10/21/25 covering other events and financials.
AI Summary
On October 21, 2025, Q32 Bio Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The company, formerly known as Homology Medicines, Inc. until December 28, 2015, is incorporated in Delaware and headquartered in Waltham, Massachusetts.
Why It Matters
This 8-K filing serves as an official notification to the SEC regarding significant events or financial updates for Q32 Bio Inc., providing transparency to investors.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain specific financial performance data or strategic announcements that would inherently increase risk.
Key Players & Entities
- Q32 Bio Inc. (company) — Registrant
- Homology Medicines, Inc. (company) — Former company name
- 20151228 (date) — Date of name change
- October 21, 2025 (date) — Date of earliest event reported
- Waltham, Massachusetts (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Q32 Bio Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits" as of October 21, 2025.
When was Q32 Bio Inc. formerly known as?
Q32 Bio Inc. was formerly known as Homology Medicines, Inc. until December 28, 2015.
Where are Q32 Bio Inc.'s principal executive offices located?
The principal executive offices are located at 830 Winter Street, Waltham, Massachusetts, 02451.
What is the SEC file number for Q32 Bio Inc.?
The SEC file number for Q32 Bio Inc. is 001-38433.
What is the SIC code for Q32 Bio Inc.?
The Standard Industrial Classification (SIC) code for Q32 Bio Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 436 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-10-21 07:05:33
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share QTTB The Nasdaq Global Ma
Filing Documents
- d43495d8k.htm (8-K) — 24KB
- d43495dex991.htm (EX-99.1) — 14KB
- g43495g1021002347702.jpg (GRAPHIC) — 3KB
- 0001193125-25-244262.txt ( ) — 154KB
- qttb-20251021.xsd (EX-101.SCH) — 2KB
- qttb-20251021_lab.xml (EX-101.LAB) — 17KB
- qttb-20251021_pre.xml (EX-101.PRE) — 11KB
- d43495d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release issued by Q32 Bio Inc. on October 21, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Q32 BIO INC. Date: October 21, 2025 By: /s/ Jodie Morrison Name: Title: Jodie Morrison Chief Executive Officer